Free Trial

Jane Street Group LLC Purchases 103,871 Shares of Owens & Minor, Inc. (NYSE:OMI)

Owens & Minor logo with Medical background

Jane Street Group LLC raised its holdings in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 126.0% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 186,280 shares of the company's stock after acquiring an additional 103,871 shares during the quarter. Jane Street Group LLC owned about 0.24% of Owens & Minor worth $2,923,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in OMI. Quarry LP lifted its stake in shares of Owens & Minor by 290.1% in the 2nd quarter. Quarry LP now owns 2,099 shares of the company's stock valued at $28,000 after purchasing an additional 1,561 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Owens & Minor by 176.8% in the third quarter. Blue Trust Inc. now owns 2,787 shares of the company's stock worth $44,000 after buying an additional 1,780 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its stake in shares of Owens & Minor by 76.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 3,126 shares of the company's stock worth $43,000 after acquiring an additional 1,356 shares in the last quarter. Innealta Capital LLC acquired a new position in shares of Owens & Minor during the 2nd quarter valued at about $43,000. Finally, Allspring Global Investments Holdings LLC raised its stake in shares of Owens & Minor by 100.6% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 6,071 shares of the company's stock valued at $82,000 after acquiring an additional 3,044 shares in the last quarter. 98.04% of the stock is owned by institutional investors.

Owens & Minor Stock Performance

Shares of NYSE OMI traded down $0.10 during trading hours on Friday, reaching $12.52. The stock had a trading volume of 2,813,476 shares, compared to its average volume of 810,074. The company has a market cap of $965.40 million, a price-to-earnings ratio of -19.26, a PEG ratio of 0.48 and a beta of 0.42. Owens & Minor, Inc. has a twelve month low of $11.42 and a twelve month high of $28.35. The business's fifty day moving average is $13.26 and its two-hundred day moving average is $14.57. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45.

Owens & Minor (NYSE:OMI - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $0.42 EPS for the quarter, topping analysts' consensus estimates of $0.41 by $0.01. The company had revenue of $2.72 billion during the quarter, compared to the consensus estimate of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period last year, the firm earned $0.44 EPS. As a group, research analysts expect that Owens & Minor, Inc. will post 1.49 EPS for the current year.

Insider Activity at Owens & Minor

In other news, CFO Jonathan A. Leon sold 5,282 shares of the company's stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $11.82, for a total value of $62,433.24. Following the completion of the sale, the chief financial officer now directly owns 130,822 shares of the company's stock, valued at $1,546,316.04. This represents a 3.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 3.59% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on OMI shares. Barclays decreased their target price on Owens & Minor from $18.00 to $14.00 and set an "equal weight" rating for the company in a research report on Tuesday, November 5th. Citigroup lowered their target price on shares of Owens & Minor from $21.00 to $18.50 and set a "buy" rating on the stock in a research note on Tuesday, November 5th. UBS Group cut their target price on shares of Owens & Minor from $28.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, November 5th. StockNews.com cut shares of Owens & Minor from a "buy" rating to a "hold" rating in a report on Monday, August 26th. Finally, Robert W. Baird dropped their price objective on Owens & Minor from $19.00 to $14.00 and set a "neutral" rating on the stock in a research note on Tuesday, November 5th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $18.50.

Get Our Latest Analysis on OMI

About Owens & Minor

(Free Report)

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.

Recommended Stories

Institutional Ownership by Quarter for Owens & Minor (NYSE:OMI)

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines